Isotop

Quick links to important sections

Isotop

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isotop

Property Description
Active ingredient Isosorbide Mononitrate
Form Solid Oral Tablet (often sustained-release)
Pharmacological class Organic Nitrate, Vasodilator
Common use Prophylactic management of cardiovascular conditions
Origin Synthetic compound

What is Isotop and Its Pharmacological Identity?

Isotop is a prescription medicine defined by its primary active ingredient, Isosorbide Mononitrate, a synthetic compound classified within the Organic Nitrate pharmacological group. This classification, recognized across major pharmacopeias, defines the medicine's core function as a Vasodilator that acts to relax vascular smooth muscle throughout the body.

The formulation, which often includes Dilute Isosorbide Mononitrate, confirms its status as a single-active-ingredient product. The Isosorbide Mononitrate compound possesses pharmacological properties that lend themselves to consistent, scheduled use in circulatory management.

Composition and General Therapeutic Role

The medicine is typically manufactured as a solid oral tablet, frequently utilizing a specialized sustained-release formulation. This controlled design is a key factor that allows the Isosorbide Mononitrate to be absorbed gradually over time, ensuring a continuous therapeutic presence rather than a rapid, short-lived effect.

The general purpose of Isotop is centered on acting as an Antianginal agent by making the heart’s function more efficient and less oxygen-demanding. The medicine is intended for the prophylactic management of chronic cardiovascular conditions, serving to prevent symptom recurrence by reducing the heart's workload, which is a key principle in stable heart support.

Regulatory References

  1. Isosorbide Mononitrate Extended-Release Tablets - DailyMed

What side effects are possible with Isotop?

Possible Side Effects and Safety Information

The safety profile of Isotop is primarily characterized by its known potential for severe adverse reactions and the need for rigorous monitoring, as defined by global regulatory agencies.

Critical Safety Considerations

Absolute Contraindication in Pregnancy: Isotop is strictly contraindicated in all pregnant women and patients who may become pregnant due to an extremely high risk of severe and life-threatening birth defects (teratogenicity). This risk mandates enrollment in a mandatory risk management program (such as a Pregnancy Prevention Programme or REMS) to minimize any fetal exposure.

Serious Adverse Reactions that have been documented in regulatory sources include:

  • Neuropsychiatric Events: Depression, mood changes, psychosis, and reports of suicidal ideation or attempts.
  • Severe Skin Reactions: Rare but serious events like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
  • Hepatobiliary and Lipid Effects: Elevation of liver enzymes (hepatotoxicity) and elevated blood lipids (hypertriglyceridemia), which can lead to acute pancreatitis.

Frequency-Classified Adverse Reactions

The majority of patients experience common and expected side effects, often related to the drying effects of the medicine. These are classified in regulatory documents based on frequency:

Classification Examples of Documented Effects
Very Common (Affecting more than 1 in 10 people) Cheilitis (dry lips), dry skin, dry eyes, back pain, joint pain, elevated blood lipid levels, inflammation of the eyelids.
Common (Affecting up to 1 in 10 people) Headache, nosebleed, elevated liver enzyme levels (reversible), inflammation of the skin.

Required Safety Monitoring and Restrictions

Mandatory Monitoring: Regular blood tests are required during therapy to check liver function tests and blood lipid levels (triglycerides) to detect and manage potential organ toxicity. Safety Restrictions: Isotop is also restricted for use in patients with pre-existing hepatic impairment, excessively high blood lipid levels, and in those taking certain antibiotics, specifically tetracyclines, due to an increased risk of Pseudotumor Cerebri (Benign Intracranial Hypertension).

Overdose and Emergency Response

A suspected overdose of Isotop (Isosorbide Mononitrate) is primarily characterized by the effects of severe and persistent vasodilation, a documented physiological consequence of excessive exposure. Officially documented clinical manifestations include profound hypotension (markedly low blood pressure), compensatory tachycardia, severe flushing, and symptoms resulting from cerebral hypoperfusion, such as syncope (fainting), dizziness, and a severe, throbbing headache. Other documented signs may include nausea, vomiting, and visual disturbances.

Regulators classify overdose as potentially severe or life-threatening due to the risk of complications like circulatory collapse and secondary myocardial ischemia. A specific, rare, but serious toxicological risk noted in regulatory labeling is Methemoglobinemia, which compromises the blood's oxygen-carrying capacity. Certain populations, including the elderly, are noted to be at increased risk for complications related to Methemoglobinemia.

In all cases of suspected overdose, the official regulatory guidance is to seek immediate medical attention and contact emergency services without delay. Symptomatic and supportive treatment is required, including measures to manage severe hypotension, such as intravenous fluid administration and continuous blood pressure monitoring in a hospital setting. The official prescribing information states that no specific antidote is known for the primary vasodilatory effects of the drug.

Therapeutic Uses of Isotop

Isotop (Isosorbide Mononitrate) is primarily used for the long-term, prophylactic management of conditions involving episodic or fluctuating manifestations. It is relevant when supportive symptom management is appropriate, but is generally not applied in clinical settings that involve acute or unstable symptom patterns.

The medicine is commonly used across conditions presenting with recurrent episodes, specifically Angina Pectoris due to Coronary Artery Disease, and is applied in addressing symptom clusters that may become intense or disruptive. The primary benefit is in helping to manage the frequency of anginal attacks, which assists with maintaining a sense of stability when symptoms are more noticeable. Its role is primarily associated with prophylactic management.


Managing Recurrent Chest Discomfort and Functional Stability

Isotop is considered relevant when supportive symptom management is appropriate, assisting in the management of symptoms linked to organ-specific functional stress (such as during exertion). Applied during phases when symptoms become more noticeable due to physical activity or stress, it contributes to improved day-to-day comfort during symptomatic periods and may help patients cope more steadily with symptom fluctuations.

“It is commonly used to help patients manage and helps ease the overall symptom burden of recurrent episodes of chest discomfort.”

Quick Fact: Supportive Relief for Recurrent Anginal Symptoms

Regulatory References

  1. Isosorbide Mononitrate Extended-Release Tablets, USP

Eligibility and Restrictions for Use

The eligibility for Isotop (Isosorbide Mononitrate) is strictly defined by regulatory documents, focusing on absolute prohibitions and use under specific caution, as follows:

Populations Who Must Not Use Isotop (Contraindications)

  • Pharmacological Incompatibility: Use is strictly prohibited with medicines containing Phosphodiesterase Type 5 (PDE5) Inhibitors (e.g., sildenafil, tadalafil) or the soluble guanylate cyclase stimulator riociguat. Concomitant use with these agents is contraindicated due to the risk of severe, life-threatening hypotension.
  • Clinical State Prohibitions: The medicine must not be used in patients with known hypersensitivity to any nitrate compound, or in the presence of severe hypotension (low blood pressure), acute circulatory failure (shock), or severe anemia.

Conditional Use and Restrictions

  • Age and Life Stage: Use is not established in the pediatric population. For older adults, use is permitted but requires caution due to a higher risk of hypotension. During pregnancy and lactation, the medicine is recommended only if the treating physician determines the benefit significantly outweighs the potential unknown risks to the baby.
  • Comorbidities: Caution is required in patients who are volume-depleted, already hypotensive, or those with hypertrophic cardiomyopathy. Use is also restricted in patients with severe obstructive heart conditions or certain hereditary metabolic disorders.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Isotop (Isosorbide Mononitrate) is primarily structured around interactions that lead to pharmacodynamic potentiation, significantly increasing the risk of severe hypotension.

Contraindicated Combinations

Co-administration is absolutely contraindicated with certain classes of medicines due to the risk of life-threatening blood pressure drops (hypotension). This prohibition applies to:

Classification Example Agents
Phosphodiesterase Type 5 (PDE5) Inhibitors Sildenafil, Tadalafil, Vardenafil
Soluble Guanylate Cyclase (sGC) Stimulators Riociguat

These restrictions are established in official regulatory labeling to prevent a dangerous cumulative vasodilatory effect.

Other Clinically Significant Interactions

Additive Hypotensive Effects may occur when Isotop is used with other medicinal products that lower blood pressure, such as Calcium Channel Blockers, other vasodilators, antihypertensive agents, or certain Neuroleptics and Tricyclic Antidepressants. Concomitant use with alcohol (ethanol) also exhibits additive vasodilating effects, increasing the risk of severe postural hypotension and related light-headedness. Furthermore, co-administration with Dihydroergotamine may increase the blood level of the latter. Regulatory documents do not require restrictions based on CYP enzyme or transporter activity for Isotop itself.

Mechanism of Action

️ How Isotop Works


Molecular Activation and NO-cGMP Cascade

The action of Isotop (Isosorbide Mononitrate) begins inside the vascular smooth muscle cells, where the molecule acts as a prodrug. It is bioactivated by intracellular co-factors to release the active signaling gas, Nitric Oxide (NO). NO then binds to and directly activates the enzyme Soluble Guanylyl Cyclase (sGC), triggering a rapid rise in the second messenger, cyclic Guanosine Monophosphate (cGMP), which acts as the direct molecular trigger for the subsequent relaxation of smooth muscle.


Systemic Vasodilation and Preload Reduction

The increase in cGMP causes the muscle cells to relax, leading to vasodilation (widening of blood vessels), with the effect being most pronounced on the venous system. By increasing the capacity of the veins, the mechanism significantly reduces the volume of blood returning to the heart, a physiological adjustment known as decreasing Preload. This reduction in volume load results in a decrease in the force and tension required for myocardial activity, altering the heart's oxygen supply-to-demand ratio.


Mechanistic Constraint: The Basis of Tolerance

The functional capacity of this mechanism is dependent on the availability of specific cellular co-factors, such as sulfhydryl groups, required for the initial bioactivation step. Frequent or continuous exposure to the drug is associated with attenuation of the mechanism, potentially linked to desensitization of the enzyme or depletion of necessary co-factors, which results in the phenomenon of nitrate tolerance, where the downstream signaling pathway exhibits a functionally diminished response.

Dosage and Administration Information

How to Use Isotop (Isosorbide Mononitrate)

Isotop, containing the active substance Isosorbide Mononitrate, is administered exclusively via the oral route as part of a long-term prophylactic management protocol. The specific dosing schedule is deliberately designed to establish a nitrate-free period each day, a critical requirement for maintaining the medicine’s long-term effectiveness.

Standard Dosing and Frequency

Dosage is determined by the specific formulation of Isosorbide Mononitrate being used:

Formulation Standard Regimen Frequency and Timing
Extended-Release (ER) Tablet 30 mg to 60 mg Once daily (OD), typically taken upon arising in the morning.
Immediate-Release (IR) Tablet 20 mg Twice daily (BD), with the two daily doses separated by approximately seven hours.

The medicine is not indicated for aborting an acute anginal episode due to its slow onset of action. The maximum dose for the ER formulation is 240 mg once daily.

Administration Guidelines

Extended-release tablets must be swallowed whole with a fluid and must not be crushed or chewed to ensure the controlled release mechanism functions correctly. The tablet may be taken with or without a meal, as its absorption is generally not significantly affected by food. For older adults (geriatric patients), treatment should commence at the low end of the dosing range. Isotop is intended for long-term use and must be tapered gradually if therapy is to be discontinued; sudden cessation is generally advised against.

Recent Clinical Evidence

Isotop: Recent Clinical Evidence

Recent clinical research focuses on the use of Isotop as a component in radiopharmaceuticals, specifically in the targeted delivery of radiation for both diagnostic imaging and therapeutic treatment, primarily in oncology. This approach utilizes radioactive isotopes bound to targeting molecules to deliver radiation directly to diseased tissues while attempting to spare healthy cells.

Efficacy and Therapeutic Studies

Clinical trials have investigated therapeutic radiopharmaceuticals that incorporate certain isotopes, such as lutetium-177 and actinium-225. These studies have reported findings suggesting that this mechanism may offer a precise method for delivering radiation to tumors. Specifically, alpha-emitting isotopes (e.g., Actinium-225) are being explored for their ability to deliver a highly concentrated, short-range radiation dose, which may be beneficial for targeting small, localized clusters of cells. Beta-emitting isotopes (e.g., Lutetium-177) are being studied for their broader range, which may be more suitable for addressing larger or more diffuse disease.

Safety and Pharmacokinetic Considerations

The clinical development of these compounds requires careful evaluation of safety. Because they are radioactive, regulatory bodies require detailed information demonstrating that the chosen isotope's half-life, radiation type, and metabolism result in the lowest possible dose to the whole body or specific organs while still providing necessary clinical information. Research has also focused on stable isotope labeling (using non-radioactive isotopes like carbon-13) as a highly sensitive method in clinical trials, particularly for pharmacokinetic assessments. This technique offers a way to monitor drug metabolism and absorption non-invasively, supporting the development of tailored treatment regimens.

Key Studies & References

  1. Clinical Trials of Lutetium-177-PSMA in Metastatic Castration-Resistant Prostate Cancer (RCT Meta-analysis)

Frequently Asked Questions (FAQ)

Common questions about Isotop (FAQ)


Q: What does the term 'mechanism of action' mean for Isotop in simple terms?

The term 'mechanism of action' describes how the drug works at a molecular level. In simple terms, the medicine acts as a vasodilator, meaning it relaxes and widens the blood vessels.

This effect reduces the heart's workload, which in turn decreases its need for oxygen.


Q: Is Isotop the same type of drug as [similar common drug name]?

According to official product information, Isotop belongs to the Organic Nitrate pharmacological class, which works as a vasodilator (a medicine that widens blood vessels).

This classification is distinct from other types of cardiovascular medications often used for similar conditions, such as beta-blockers or calcium channel blockers.


Q: What's the main difference between Isotop and other treatments for [condition]?

Official information indicates that this nitrate class specifically works by relaxing blood vessels throughout the body.

This action reduces the heart’s workload and oxygen demand, which is the primary mechanical difference from other treatments for chronic cardiovascular conditions.


Q: How quickly can someone expect Isotop to start working?

According to the official product information, the onset of activity for the immediate-release formulation is typically within 20 to 30 minutes.

Official guidance confirms that this medication is intended for the prevention of symptoms as part of a long-term management protocol, and is not indicated for stopping an acute episode already in progress.


Q: How long does the effect of one dose of Isotop usually last?

The antianginal effect of the extended-release formulation is designed to last for approximately 8 to 10 hours.

This specific duration is intended to allow for the necessary daily 'nitrate-free period' to prevent the development of drug tolerance.


Q: Is it okay to take Isotop with pain relievers like Tylenol or Advil?

Paracetamol (Acetaminophen) is frequently used to manage nitrate-induced headaches and is generally not listed among the contraindicated interactions.

However, the use of NSAIDs (such as ibuprofen) is described in some official information as potentially requiring caution in individuals with certain underlying heart conditions.


Q: Are there any common foods or drinks that interact with Isotop?

The medication may be taken with or without a meal, as its absorption is generally not significantly affected by food.

Official warnings state that consuming alcohol can increase the risk of hypotensive side effects, such as dizziness and fainting, due to additive vasodilating effects.


Q: Does Isotop interact with caffeine or alcohol?

Alcohol consumption is described as having additive vasodilating effects and may increase the risk of severe postural hypotension (dizziness upon standing).

Official documents generally do not list caffeine as a clinically significant interaction.


Q: Are there known interactions between Isotop and herbal supplements?

Official guidance indicates that there is generally limited or insufficient data available to define the interaction profile of complementary medicines, herbal remedies, or other dietary supplements with this prescription drug.


Q: Does Isotop interact with birth control pills?

Official patient information indicates that the medicine is not reported to stop any type of contraception from working.

This includes hormonal birth control pills or other forms of emergency contraception.


Q: What should I know about Isotop if I have liver or kidney problems?

Official documents advise that caution may be necessary for individuals with severe hepatic (liver) or renal (kidney) impairment.

Some regulatory sources advise dosage reduction in these cases because the drug is metabolized and eliminated by these organs.


Q: Can people with a history of heart issues take Isotop?

Official safety information indicates that use is restricted or strictly prohibited for people with certain severe heart conditions.

This includes conditions like very low blood pressure (severe hypotension), acute circulatory failure, and certain obstructive heart diseases like hypertrophic cardiomyopathy.


Q: Why is Isotop available only by prescription?

The drug is officially classified as a Legend Drug (prescription-only medicine) because it is intended for a serious underlying cardiovascular condition.

This classification is based on the need for professional medical supervision for diagnosis, dosage determination, and ongoing monitoring of its significant side effect and interaction profile.


Q: Is there a generic version of Isotop available?

Official records and drug registries confirm that the active ingredient, Isosorbide Mononitrate, is available as a generic medication in many regions worldwide.


Q: Is Isotop commonly used in other countries besides the US/UK?

The active ingredient, Isosorbide Mononitrate, is widely used globally.

It is marketed under various trade names in many countries besides the US and UK, including regions such as Australia and India.


Q: How is the effectiveness of Isotop generally measured in clinical studies?

Effectiveness in clinical studies is generally measured by evaluating specific changes in patient outcomes.

This often includes improvements in the patient's exercise tolerance and a recorded reduction in the frequency of anginal attacks.


Q: What kind of studies or research support the use of Isotop?

Studies and official product information note that the antianginal efficacy of the drug is assessed in clinical trials.

This is typically measured by evaluating how often patients experience angina attacks and by using tests like exercise tolerance testing.


Q: What is known about the research on long-term effects of Isotop?

Official labeling addresses the effects of chronic dosing by discussing the necessity of a 'nitrate-free period' to prevent the development of nitrate tolerance.

Research has examined this mechanism of tolerance, which can cause a loss of efficacy during long-term use.


Q: What if Isotop doesn't seem to be working after the initial period?

According to official patient information, if the medication doesn't seem to be working, it may be due to the development of nitrate tolerance (where the body adjusts to the drug).

Official guidance states that if chest pain begins to happen more often or becomes more severe, consultation with a healthcare provider is recommended.


Q: What are the most common reasons someone might stop taking Isotop?

Official documents note that some common side effects, such as headaches and light-headedness, have been noted as reasons for discontinuing treatment.

Another known reason for potential discontinuation is a loss of efficacy due to the development of nitrate tolerance.


Q: Does taking Isotop require any lifestyle changes?

Official guidance mentions that reducing or avoiding alcohol consumption is often necessary due to the risk of additive side effects.

Additionally, general health guidelines often recommend measures like a healthy diet and regular exercise to help manage the underlying cardiovascular condition.


Q: What happens if a dose of Isotop is missed?

Official guidance suggests that if a dose is missed, it may be taken as soon as it is remembered.

However, if it is almost time for the next scheduled dose, the missed dose is generally advised to be skipped to prevent potential dosing overlap.


Q: What should I do if I suspect an interaction between Isotop and another medicine?

Official guidance notes that consultation with a doctor or pharmacist is advised to discuss any medications—including those available over-the-counter or herbal products—before starting, stopping, or changing any treatments.

This ensures safe use based on the known interaction profile.


Q: What if I take too much Isotop—what information do official sources provide about overdose?

Official product information describes potential overdose symptoms, which may include severe hypotension (very low blood pressure), flushing, nausea, and vomiting.

More serious reported effects include tachycardia (fast heart rate) and a blood disorder called methemoglobinemia (a condition affecting oxygen transport).


Q: Does Isotop affect my ability to drive or operate machinery?

Regulatory documents warn that the drug may cause side effects such as dizziness, drowsiness, or blurred vision, especially when treatment begins.

Official guidance therefore suggests against driving or operating hazardous machinery if a person is affected by these symptoms.


Q: Is Isotop associated with fatigue or changes in energy levels?

Reported side effects listed in regulatory documents include dizziness and a feeling of weakness (sometimes associated with low blood pressure), which can resemble reduced energy levels.

These effects are typically observed at the beginning of treatment.


Q: Can someone be allergic to Isotop, and what are the signs?

Official documents state that a known hypersensitivity to any nitrate compound is an absolute contraindication for use.

Signs of serious allergic reaction reported in patient information include symptoms such as rash, hives, itching, or difficulty breathing or swallowing.


Q: How does the drug authority classify the safety profile of Isotop?

The drug is officially classified as a Legend Drug (prescription-only medicine) by regulatory authorities.

This classification is necessary due to the medication’s use in treating a serious condition and mandatory monitoring for potentially severe effects like hypotension.


Q: How does official guidance describe the need for follow-up appointments when taking Isotop?

Official guidance mandates regular blood tests during therapy to monitor parameters such as liver function and blood lipid levels to detect potential organ toxicity.

The need for clinical supervision and monitoring of these required tests implies the necessity of follow-up with a healthcare provider.

How should Isotop be stored and disposed of?

Storage and Protection Requirements

Isotop (Isosorbide Mononitrate) tablets must be stored at Controlled Room Temperature, defined by regulatory standards as 20 C to 25 C (68 F to 77 F), with permitted short excursions between 15 C to 30 C (59 F to 86 F). The product must be protected from excessive moisture, heat, and humidity to ensure its stability.

Packaging and Child Safety

Tablets must be kept in their tightly closed container as supplied. For child safety, the medicine must be stored out of the sight and reach of children at all times.

Disposal Instructions

Unused or expired Isotop should be disposed of in accordance with local regulations, often through a drug take-back program or a regulated household disposal method. The product must not be flushed down the toilet or poured into a drain unless explicitly instructed by the official labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Isotop found in:

A-Z Index: